» Articles » PMID: 32953940

Computationally Designed 3D Printed Self-Expandable Polymer Stents with Biodegradation Capacity for Minimally Invasive Heart Valve Implantation: A Proof-of-Concept Study

Overview
Date 2020 Sep 21
PMID 32953940
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The evolution of minimally invasive implantation procedures and the remodeling potential of decellularized tissue-engineered heart valves require stents with growth capacity to make these techniques available for pediatric patients. By means of computational tools and 3D printing technology, this proof-of-concept study demonstrates the design and manufacture of a polymer stent with a mechanical performance comparable to that of conventional nitinol stents used for heart valve implantation in animal trials. A commercially available 3D printing polymer was selected, and crush and crimping tests were conducted to validate the results predicted by the computational model. Finally, the degradability of the polymer was assessed via accelerated hydrolysis.

Citing Articles

Recent research progresses of bioengineered biliary stents.

Yan J, Ye Z, Wang X, Zhong D, Wang Z, Yan T Mater Today Bio. 2024; 29:101290.

PMID: 39444940 PMC: 11497374. DOI: 10.1016/j.mtbio.2024.101290.


Investigation of 3D Printed Bioresorbable Vascular Scaffold Crimping Behavior.

Collins C, Leng J, Fu R, Ding Y, Ameer G, Sun C Adv Mater Technol. 2024; 9(8).

PMID: 39247925 PMC: 11376437. DOI: 10.1002/admt.202301698.


Additive manufacturing of sustainable biomaterials for biomedical applications.

Arif Z, Khalid M, Noroozi R, Hossain M, Shi H, Tariq A Asian J Pharm Sci. 2023; 18(3):100812.

PMID: 37274921 PMC: 10238852. DOI: 10.1016/j.ajps.2023.100812.


219Three-dimensional printing as a cutting-edge, versatile and personalizable vascular stent manufacturing procedure: Toward tailor-made medical devices.

Garcia-Villen F, Lopez-Zarraga F, Viseras C, Ruiz-Alonso S, Al-Hakim F, Diez-Aldama I Int J Bioprint. 2023; 9(2):664.

PMID: 37065659 PMC: 10090821. DOI: 10.18063/ijb.v9i2.664.


Combining Cell Technologies With Biomimetic Tissue Engineering Applications: A New Paradigm for Translational Cardiovascular Therapies.

Motta S, Martin M, Gahwiler E, Visser V, Zaytseva P, Ehterami A Stem Cells Transl Med. 2023; 12(2):72-82.

PMID: 36806699 PMC: 9985110. DOI: 10.1093/stcltm/szad002.


References
1.
Kornowski R, Hong M, Tio F, Bramwell O, Wu H, Leon M . In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol. 1998; 31(1):224-30. DOI: 10.1016/s0735-1097(97)00450-6. View

2.
Mayoral W, Fleischer D, Salcedo J, Roy P, Al-Kawas F, Benjamin S . Nonmalignant obstruction is a common problem with metal stents in the treatment of esophageal cancer. Gastrointest Endosc. 2000; 51(5):556-9. DOI: 10.1016/s0016-5107(00)70289-6. View

3.
Yacoub M, Takkenberg J . Will heart valve tissue engineering change the world?. Nat Clin Pract Cardiovasc Med. 2005; 2(2):60-1. DOI: 10.1038/ncpcardio0112. View

4.
Vert M . Aliphatic polyesters: great degradable polymers that cannot do everything. Biomacromolecules. 2005; 6(2):538-46. DOI: 10.1021/bm0494702. View

5.
Schmidt D, Dijkman P, Driessen-Mol A, Stenger R, Mariani C, Puolakka A . Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells. J Am Coll Cardiol. 2010; 56(6):510-20. DOI: 10.1016/j.jacc.2010.04.024. View